Optio Venture Partners

Unique Tumor Repository Launched by UCLA

They hope to use this information to increase their knowledge of HLRCC which could possibly lead to better prevention strategies, early diagnosis, and more effective treatment in the future. Patients can participate remotely (or in person) as long as consent is obtained.
You can find more information about the study at:
For more information, please contact:
Brian Shuch, MD
Shirin Zavoshi, MD
310-794-9493

Related post: Viagra

Related topic: Aricept

This is a staging enviroment